Zim Laboratories quarterly results and financials

Zim Laboratories (ZIMLAB)₹136.86+1.74%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Jun 2026 quarter (consolidated), Zim Laboratories reported sales of ₹94.17 Cr, up 31.4% from Jun 2025, and net profit of −₹4.01 Cr. For the year to Mar 2026, sales were ₹374 Cr and net profit ₹5.98 Cr.

Sales (Jun 2026): ₹94.17 Cr
Net profit (Jun 2026): −₹4.01 Cr
Sales (FY Mar 2026): ₹374 Cr
Net profit (FY Mar 2026): ₹5.98 Cr
EPS (Jun 2026): ₹−0.76
Borrowings (Mar 2026): ₹126 Cr

Company filings, consolidated accounts; latest reported quarter Jun 2026

Zim Laboratories quarterly results

₹ crore unless stated; each column is a quarter.

Zim Laboratories Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	85.75	96.22	118	81.73	92.07	96.22	109	71.66	88.64	109	105	94.17
Expenses	76.34	84.57	102	73.68	82.43	84.69	94.03	67.43	82.83	95.64	97.96	91.63
Operating Profit	9.34	11.55	15.66	8.05	9.54	11.55	14.61	4.26	5.77	12.82	7.20	2.44
OPM %	10.8%	11.9%	13.2%	9.8%	10.3%	11.9%	13.4%	5.9%	6.5%	11.7%	6.8%	2.6%
Other Income	1.43	1.12	1.54	1.01	1.33	1.76	1.72	1.49	2.05	1.71	6.19	1.00
Interest	1.21	1.69	2.27	2.85	2.88	2.72	2.90	3.29	3.15	3.42	3.30	3.63
Depreciation	4.07	3.93	3.89	4.92	4.98	4.86	5.27	4.84	4.96	5.01	5.08	5.35
Profit before tax	5.43	7.02	10.98	1.23	2.97	5.69	8.12	−2.44	−0.33	6.06	4.95	−5.56
Tax %	23.7%	31.8%	26.5%	27.4%	19.6%	30.0%	39.7%	−22.6%	23.5%	27.3%	24.3%	−28.0%
Net Profit	4.14	4.77	8.07	0.89	2.37	3.99	4.87	−1.86	−0.41	4.38	3.73	−4.01
EPS (Rs)	0.86	0.99	1.67	0.19	0.50	0.83	1.01	−0.39	−0.10	0.91	0.71	−0.76

Zim Laboratories profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Zim Laboratories Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	269	235	273	335	278	307	333	399	367	379	374	397
Expenses	239	203	237	293	255	268	291	346	325	335	344	368
Operating Profit	30.01	32.01	35.01	41.99	22.99	39.98	41.02	51.99	41.02	44.02	30.02	28.23
OPM %	11.0%	13.0%	12.9%	13.0%	8.0%	13.0%	11.9%	12.9%	10.9%	12.0%	8.0%	7.1%
Other Income	−2.01	5.02	9.03	2.01	5.02	−3.01	4.01	6.02	5.02	6.02	11.05	10.95
Interest	13.98	9.99	8.99	10.99	12.98	10.99	7.99	5.99	6.99	10.99	12.98	13.50
Depreciation	8.97	8.97	9.96	10.96	13.95	15.94	15.94	16.93	15.94	19.93	19.94	20.40
Profit before tax	5.01	17.99	24.98	21.98	0.00	9.99	20.99	34.99	23.99	18.01	8.01	5.12
Tax %	5.0%	−6.0%	23.0%	30.0%	−4,600.0%	28.0%	31.0%	31.0%	27.0%	32.0%	29.0%	—
Exceptional items	−4.02	0.00	4.01	0.00	0.00	−4.01	0.00	0.00	0.00	0.00	1.01	—
Net Profit	4.98	18.95	18.94	14.95	2.99	6.98	14.96	23.92	16.95	11.97	5.98	3.69
EPS (Rs)	—	—	—	3.18	0.69	1.51	3.00	5.03	3.56	2.51	1.10	0.76
Dividend payout %	16.0%	4.0%	4.0%	5.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Zim Laboratories balance sheet

₹ crore, at each year end.

Zim Laboratories Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	8.01	8.00	8.01	7.99	15.99	15.99	16.01	16.01	49.01	49.01	49.02	54.01
Reserves	86.15	91.17	110	129	135	138	145	159	152	190	204	244
Borrowings	92.66	95.73	80.78	80.70	76.76	89.64	81.76	52.85	61.79	112	118	126
Other Liabilities	78.34	61.29	60.29	81.29	100	82.38	82.13	112	79.19	96.35	102	116
Total Liabilities	265	256	259	298	328	325	325	342	342	447	472	539
Fixed Assets	86.87	91.75	88.86	93.83	106	116	107	106	109	161	164	162
CWIP	5.99	2.99	3.99	7.99	12.98	9.97	10.98	11.98	26.97	41.92	69.92	95.76
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	172	161	167	196	210	201	209	225	207	245	238	283
Inventories	45.89	37.89	34.91	51.89	54.83	55.84	53.88	74.79	53.86	80.75	85.72	93.73
Trade receivables	81.01	88.94	87.90	88.91	92.98	67.97	71.95	89.88	94.99	99.91	107	109
Cash & equivalents	8.03	6.01	6.01	4.01	3.01	4.01	8.02	5.01	8.03	10.03	2.01	43.12
Total Assets	265	256	259	298	328	325	325	342	342	447	472	539

Zim Laboratories cash flow

₹ crore, for each year.

Zim Laboratories Cash flow
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	22.03	32.03	37.07	35.03	22.03	32.04	49.03	38.08	16.03	41.07	50.05
Cash from investing activity	−11.99	−6.99	−25.96	−20.97	−18.98	−5.99	−13.98	−34.96	−72.93	−39.94	−54.99
Cash from financing activity	−10.02	−25.03	−10.02	−15.02	−2.01	−26.06	−33.04	1.01	60.06	−9.02	28.06
Net cash flow	0.00	0.00	1.01	−1.01	1.01	0.00	2.01	3.01	3.01	−8.01	23.02
Capex	13.20	8.92	28.62	20.46	18.60	6.50	15.29	36.80	74.22	40.92	44.55
Free cash flow	9.01	24.02	8.01	15.01	3.01	25.02	34.04	1.01	−57.05	1.01	11.02
CFO / OP %	77.0%	109.0%	117.0%	85.0%	119.0%	83.0%	121.0%	86.0%	46.0%	92.0%	177.0%

Zim Laboratories ratios

Working-capital days and returns, by year.

Zim Laboratories Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	112	121	138	120	102	90	87	99	88	101	104	107
Inventory days	93	87	108	134	126	144	125	171	99	173	188	207
Days payable	128	108	136	171	164	167	148	184	106	132	150	160
Cash conversion cycle	75	99	108	81	63	65	62	85	79	140	140	152
Working capital days	37	33	53	36	38	45	48	66	66	56	59	40
ROCE %	—	13.1%	14.0%	14.1%	15.1%	5.0%	11.0%	12.0%	17.0%	10.0%	8.0%	5.0%

Zim Laboratories: frequently asked questions

What are the latest quarterly results of Zim Laboratories?

For the Jun 2026 quarter, Zim Laboratories reported sales of ₹94.17 Cr, up 31.4% year on year and net profit of −₹4.01 Cr. The operating margin was 2.6%.

What is the annual revenue of Zim Laboratories?

Zim Laboratories' sales for the year to Mar 2026 were ₹374 Cr; over the last twelve months they were ₹397 Cr.

What is the net profit of Zim Laboratories?

Net profit for the year to Mar 2026 was ₹5.98 Cr, and ₹3.69 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.76.

How much debt does Zim Laboratories have?

Zim Laboratories reported borrowings of ₹126 Cr at Mar 2026, against cash and equivalents of ₹43.12 Cr.

What is the free cash flow of Zim Laboratories?

Cash from operations was ₹50.05 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹11.02 Cr.

Loading…